More Investing
View Older Stories View Newer Stories-
Ipsen slips despite raising outlook on broad-based drug sales growth
-
Norwegian Cruise Line falls on weak guidance despite Q2 earnings beat
-
Arm Holdings beats Q1 estimates, shares fall in after-hours
-
Qualcomm falls on weak fourth quarter earnings guidance
-
Meta sinks 8% after Q3 revenue forecast misses Wall Street estimates
-
AT&T and Verizon tumble as Musk’s SpaceX plots direct mobile threat
-
VINCI beats first-half estimates on energy growth
-
Mercedes CEO says intense China competition is "a new reality"
-
Canada seeks more stable trade ties with US, Carney says
-
Court revives suit claiming Atlantic City casinos used AI to overcharge clients
-
Bank of Canada governors split on recovery outlook, minutes show
-
CoreWeave said to sweeten $2.6 billion loan terms amid debt concerns
-
Airbus CEO confirms 2026 delivery target range of 850 to 890 jets
-
Generalist AI seeks funding at $3 billion valuation - Business Insider
-
OpenAI offers free AI access to 100,000 academic researchers
-
Netflix to pay $200M for US Women’s World Cup broadcast rights - report
-
L’Oréal posts 6.8% H1 sales growth, record margins
-
Telecom Italia reports growth in second quarter earnings
-
Airbus Q2 profit jumps on stronger aircraft deliveries, keeps 2026 outlook
-
Italy and US to sign AI supply chain agreement on Friday
-
Cyclosporiasis outbreak in Michigan surpasses 10,000 cases
-
Neostellar’s Willy Lee: waiting for the IPO isn’t the deal it used to be
-
Teva seeks clarity on Trump drug tariff plans, CEO says
-
Bloomberg to acquire private markets data firm Canoe Intelligence
-
Baird downgrades Caterpillar to Neutral on rising data center regulatory risks
-
DoorDash secures FAA approval to launch in-house commercial drone service
-
Goldman bullish on Swissquote as core businesses offset crypto weakness
-
KeyBanc bullish on Reddit, sees a "durable compounder" in AI-linked growth
-
Amphenol beats Q2 estimates, raises Q3 outlook on AI-driven demand
-
Kepler upgrades Swatch to Buy, sees earnings recovery driving re-rating
-
JPMorgan maps Fed decision scenarios as Wall Street braces for surprise rate hike
-
Direxion unveils options income ETF suite tied to Nvidia, Tesla and other megacap
-
Citi upgrades Ford to Buy on improving F-Series momentum, lifts PT to $20
-
Is the AI rally running out of steam?
-
South Korea to impose limits on single-stock leveraged ETFs
-
S&P says El Niño alone unlikely to trigger rating downgrades
-
Banca Generali posts record first-half profit of €279m
-
How will the S&P 500 react to today’s FOMC? JPM lays out the playbook
-
Procter & Gamble falls on weak sales, cautious guidance
-
Boston Scientific stock gains as medical device maker tops Q2 forecasts
-
Logitech falls 7% on Q3 sales warning from supplier shutdown
-
Vertiv shares sink as Q2 revenue miss offsets upgraded guidance
-
Biogen Q2 revenue, adjusted EPS beat estimates as growth portfolio lifts sales
-
Humana falls despite beating second quarter estimates
-
VF falls on earnings miss despite revenue beat
-
GE HealthCare beats estimates as orders surge to record high
-
UK regulator probes Microsoft over subscription marketing
-
Boeing wins $213M Navy contract for P-8A aircraft work
-
Ferrovial posts revenue growth in first half of 2026
-
Bloom Energy jumps 8% in after hours after record revenue, raises 2026 outlook
